KBC Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97M Sell
172,679
-136,701
-44% -$87.7M 0.24% 91
2025
Q4
$209M Buy
309,380
+134,493
+77% +$91.6M 0.48% 36
2025
Q3
$112M Buy
174,887
+89,220
+104% +$54.2M 0.27% 79
2025
Q2
$45.9M Buy
85,667
+8,130
+10% +$3.89M 0.12% 155
2025
Q1
$32.6M Sell
77,537
-10,826
-12% -$4.7M 0.1% 205
2024
Q4
$36.5M Sell
88,363
-12,585
-12% -$5.52M 0.1% 201
2024
Q3
$51M Buy
100,948
+29,388
+41% +$14.3M 0.15% 134
2024
Q2
$34.9M Buy
71,560
+4,606
+7% +$2.31M 0.11% 173
2024
Q1
$36.2M Sell
66,954
-16,898
-20% -$9.23M 0.11% 172
2023
Q4
$46.5M Sell
83,852
-50,136
-37% -$23.5M 0.17% 139
2023
Q3
$58.6M Buy
133,988
+31,942
+31% +$15.9M 0.24% 93
2023
Q2
$51.3M Sell
102,046
-3,497
-3% -$1.68M 0.21% 99
2023
Q1
$52.8M Buy
105,543
+41,349
+64% +$19.8M 0.22% 97
2022
Q4
$26.2M Sell
64,194
-18,006
-22% -$6.99M 0.13% 178
2022
Q3
$26.8M Sell
82,200
-7,358
-8% -$2.7M 0.14% 161
2022
Q2
$31.4M Buy
89,558
+3,945
+5% +$1.61M 0.16% 162
2022
Q1
$46.8M Sell
85,613
-25,675
-23% -$13.5M 0.19% 132
2021
Q4
$73.3M Sell
111,288
-6,469
-5% -$4.06M 0.24% 106
2021
Q3
$73.2M Sell
117,757
-129,455
-52% -$87M 0.27% 88
2021
Q2
$156M Sell
247,212
-23,146
-9% -$12.8M 0.28% 79
2021
Q1
$132M Buy
270,358
+27,308
+11% +$13.7M 0.27% 86
2020
Q4
$668M Sell
243,050
-30,946
-11% -$13.8M 0.29% 84
2020
Q3
$108M Sell
273,996
-37,614
-12% -$13.9M 0.32% 76
2020
Q2
$103M Buy
311,610
+148,753
+91% +$43.1M 0.34% 63
2020
Q1
$39.5M Sell
162,857
-28,545
-15% -$7.45M 0.33% 66
2019
Q4
$50M Buy
191,402
+142,274
+290% +$37.5M 0.32% 63
2019
Q3
$13.4M Buy
49,128
+29,912
+156% +$8.32M 0.1% 251
2019
Q2
$5.29M Sell
19,216
-959
-5% -$236K 0.04% 422
2019
Q1
$4.51M Buy
20,175
+6,555
+48% +$1.35M 0.04% 438
2018
Q4
$2.53M Sell
13,620
-3,905
-22% -$801K 0.03% 477
2018
Q3
$4.38M Sell
17,525
-827
-5% -$201K 0.03% 462
2018
Q2
$4M Buy
18,352
+2,142
+13% +$441K 0.03% 452
2018
Q1
$3.1M Sell
16,210
-1,918
-11% -$354K 0.03% 482
2017
Q4
$2.83M Sell
18,128
-2,052
-10% -$323K 0.02% 505
2017
Q3
$3.14M Buy
20,180
+4,171
+26% +$659K 0.03% 494
2017
Q2
$2.58M Buy
16,009
+7,419
+86% +$1.2M 0.03% 522
2017
Q1
$1.33M Sell
8,590
-1,338
-13% -$184K 0.01% 763
2016
Q4
$1.17M Buy
9,928
+543
+6% +$62K 0.01% 810
2016
Q3
$1.06M Buy
9,385
+2,779
+42% +$293K 0.01% 746
2016
Q2
$613K Buy
6,606
+6,422
+3,490% +$551K 0.01% 822
2016
Q1
$14K Hold
184
﹤0.01% 1238
2015
Q4
$13K Sell
184
-594
-76% -$42.4K ﹤0.01% 1245
2015
Q3
$58K Sell
778
-1,226
-61% -$87.8K ﹤0.01% 1210
2015
Q2
$129K Sell
2,004
-37,548
-95% -$2.6M ﹤0.01% 1204
2015
Q1
$3.06M Buy
39,552
+37,110
+1,520% +$2.89M 0.04% 421
2014
Q4
$181K Sell
2,442
-9,834
-80% -$690K ﹤0.01% 1226
2014
Q3
$723K Sell
12,276
-2,442
-17% -$154K 0.03% 628
2014
Q2
$983K Buy
14,718
+748
+5% +$47.6K 0.01% 754
2014
Q1
$848K Hold
13,970
0.01% 694
2013
Q4
$743K Sell
13,970
-388
-3% -$20.4K 0.01% 749
2013
Q3
$715K Buy
14,358
+578
+4% +$27.8K 0.01% 746
2013
Q2
$618K Buy
+13,780
New +$602K 0.01% 772

Other funds holding IDXX

KBC Group's IDXX Position: Q1 2026 in Review

KBC Group reduced its Idexx Laboratories (IDXX) stake by 44% in Q1 2026, selling an estimated $87.7M and leaving 172,679 shares worth $97M. The position accounts for 0.24% of the portfolio, ranked #91.

KBC Group first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $668M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • KBC Group held 172,679 shares of Idexx Laboratories worth $97M as of Q1 2026.
  • KBC Group sold 136,701 Idexx Laboratories shares in Q1 2026, an estimated $87.7M.
  • Idexx Laboratories made up 0.24% of KBC Group's portfolio in Q1 2026, its #91 holding.
  • KBC Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Idexx Laboratories position peaked at $668M in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.